EMD 0.00% 3.2¢ emyria limited

Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 786 Posts.
    lightbulb Created with Sketch. 250
    "Over 200 patients now pre-screened, with rate of patient dosing expected to increase due to significant early engagement and ongoing support from Emerald Clinics."

    Sounds like the dates provided in the trial registry ANZCTR would be worst case scenario and the language in this announcement means we will be ahead of schedule.
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $13.29M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $8.187K 248.7K

Buyers (Bids)

No. Vol. Price($)
4 202839 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.7¢ 15000 1
View Market Depth
Last trade - 13.34pm 14/11/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.